Various transcriptional regulators have been postulated to be responsible for this effect such as increased binding of the positive factor FOXD3 in melanoma [26] or decrease binding of the negative factor CTBP1 in thyroid cancer [25]. This evidence concerns the gene FOXD3 and thyroid gland carcinoma.